Naturhouse HealthXMAD:NTH -0.78%81 Return-on-Tangible-Equity is 36.44% as of Dec. 2025, which is 20% below its 10-year median of 45.54. GuruFocus rates XMAD:NTH with a GF Score™ of 81/100 and a GF Value™ of €1.62 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 1,872 Consumer Packaged Goods companies, Naturhouse Health ranks better than 91.45% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Naturhouse Health's annualized net income for the quarter that ended in Dec. 2025 was €7.81 Mil. Naturhouse Health's average shareholder tangible equity for the quarter that ended in Dec. 2025 was €21.43 Mil. Therefore, Naturhouse Health's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2025 was 36.44%.
The historical rank and industry rank for Naturhouse Health's Return-on-Tangible-Equity or its related term are showing as below:
XMAD:NTH'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 30.82 Med: 45.54 Max: 100.3
Current: 40.82
During the past 13 years, Naturhouse Health's highest Return-on-Tangible-Equity was 100.30%. The lowest was 30.82%. And the median was 45.54%.
XMAD:NTH's Return-on-Tangible-Equity is ranked better than 91.45% of 1872
companies
in the Consumer Packaged Goods industry
Industry Median: 7.715
vs XMAD:NTH: 40.82
Naturhouse Health (XMAD:NTH) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Naturhouse Health Return-on-Tangible-Equity Related Terms
Naturhouse Health Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Naturhouse Health's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XMAD:NTH vs KHC, GIS, HRL: Return-on-Tangible-Equity Comparison
For the Packaged Foods subindustry, Naturhouse Health's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Naturhouse Health Return-on-Tangible-Equity vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Naturhouse Health's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Naturhouse Health's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Dec. 2025) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 36.44% mean?
Naturhouse Health (XMAD:NTH) has a Return-on-Tangible-Equity of 36.44% as of Dec. 2025. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Naturhouse Health and its competitors. This is 20% below median its historical median of 45.54. Over the past decade, Naturhouse Health's Return-on-Tangible-Equity has ranged from 30.82 to 100.30. According to the industry distribution chart, Naturhouse Health ranks #160 out of 1872 companies in the Consumer Packaged Goods industry, placing it in the top 8.5%.
Is Naturhouse Health's Return-on-Tangible-Equity too high?
Naturhouse Health's current Return-on-Tangible-Equity of 36.44% is 20% below median its 10-year median of 45.54. Over the past 10 years, this metric has ranged from a low of 30.82 to a high of 100.30. The Consumer Packaged Goods industry median Return-on-Tangible-Equity is 7.72. Naturhouse Health's value of 36.44% is 372.3% above this industry median. Based on the distribution chart, Naturhouse Health ranks #160 out of 1872 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Naturhouse Health has a GF Score™ of 81/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Naturhouse Health's Return-on-Tangible-Equity compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Naturhouse Health ranks #160 out of 1872 companies for Return-on-Tangible-Equity. This places Naturhouse Health in the top 9% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Equity is 7.72. Naturhouse Health's value of 36.44% is 372.3% above this benchmark. Historically, Naturhouse Health's own Return-on-Tangible-Equity has ranged from 30.82 to 100.30 over the past decade. While the company's 10-year median is 45.54 vs. the industry median of 7.72, Naturhouse Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Consumer Packaged Goods company?
The median Return-on-Tangible-Equity among Consumer Packaged Goods companies is 7.72, based on 1,872 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Naturhouse Health's current Return-on-Tangible-Equity of 36.44% is 372.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Naturhouse Health and its competitors. For the Consumer Packaged Goods industry, the median Return-on-Tangible-Equity is 7.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Naturhouse Health's current Return-on-Tangible-Equity is 36.44%, which is 20% below median its own 10-year median of 45.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Naturhouse Health stock overvalued right now?
Based on GuruFocus' analysis, Naturhouse Health (XMAD:NTH) is currently considered Significantly Overvalued. The stock's GF Value™ is €1.62, compared to a current price of €2.54 — trading 56.8% above its estimated fair value. The current Return-on-Tangible-Equity is 36.44%, which is 20% below median its 10-year median of 45.54 and 372.3% above the Consumer Packaged Goods industry median of 7.72. Naturhouse Health's overall GF Score™ is 81/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Naturhouse Health (XMAD:NTH), the current Return-on-Tangible-Equity is 36.44% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Naturhouse Health (XMAD:NTH) Overvalued in 2026?
Based on GuruFocus' analysis, Naturhouse Health stock appears to be overvalued.
The current stock price of €2.54 is trading 56.8% above its estimated GF Value™ of €1.62.
GuruFocus considers Naturhouse Health to be Significantly Overvalued.
Key valuation signals for XMAD:NTH:
Return-on-Tangible-Equity: 36.44% (20% below median its 10-year median of 45.54)
GF Value™: €1.62 vs. price of €2.54 (56.8% above fair value)
Industry Position: 372.3% above the Consumer Packaged Goods median (#160 of 1872)
No single metric tells the full story. See the XMAD:NTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Naturhouse Health SA provides nutrition & weight management products. The activity of the company is the export, wholesale, and retail sales of all kinds of products related to dietetics, herbal remedies, and natural cosmetics, as well as the preparation, promotion, creation, edition, dissemination, sale, and distribution of all kinds of magazines, books, and brochures and the marketing of dietary products, herbal remedies, and natural cosmetics. This activity is mainly carried out through franchisees and its stores. The geographical segments of the company are Spain, France, Italy, Poland, and Other countries.
81GF Score
Get the complete analysis for XMAD:NTH
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XMAD:NTH has been successfully added to your 
